I’m old enough to remember when there was no annual open enrollment. You got health insurance through your employer, and unless you changed jobs or had a major life event, you kept the same plan. Year after year. Simple. Stable. Sane.
Today, we’ve built a multibillion-dollar theater production called “open enrollment” that costs more to stage than many small countries spend on their entire health care systems. American health care wastes about $248 billion annually on excess administrative costs, and open enrollment sits at the heart of this hemorrhage. Broker commissions, marketing materials, comparison portals, HR staff hours and the entire infrastructure of manufactured “choice” siphons money that could pay for nurses, doctors and actual patient care.
The promise was competition. Give Americans annual choices among plans, the thinking went, and market forces would drive quality up and costs down. But here’s what actually happened: We created a system in which insurers pay brokers a commission for the employers they sign up — usually a healthy 3% to 6% of the total premium, potentially $50,000 a year for a midsize company — incentivizing them to sell higher-cost plans regardless of quality. We built elaborate comparison tools that let consumers agonize over premiums and deductibles while hiding the only number that actually matters: denial rates.
I learned this the hardest way possible. In 2018, my wife battled aggressive breast cancer. We had dutifully chosen our plan during open enrollment, comparing all the metrics the system told us mattered. None of it prepared us for the cascade of denials we’d face when we actually needed care. Necessary medications labeled “not medically necessary.” Treatments our plan “covered” suddenly requiring endless appeals and out-of-pocket costs.
You know what I’ve learned? The plan you chose during open enrollment is virtually indistinguishable from the one you didn’t choose when it comes to actual claim approvals. The careful comparisons, the HR seminars, the decision tools — it’s all theater. Despite record marketplace enrollment of over 20 million Americans in 2024, denial patterns remain hidden, unregulated and devastating.
